ASX - Delayed Quote AUD

Invex Therapeutics Ltd (IXC.AX)

Compare
0.0700
0.0000
(0.00%)
As of January 29 at 3:42:02 PM GMT+11. Market Open.
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
3,347.9600
3,347.9600
8,979.2860
4,241.6800
2,442.6960
Operating Income
-3,347.9600
-3,347.9600
-8,979.2860
-4,241.6800
-2,442.6960
Net Non Operating Interest Income Expense
491.8180
491.8180
797.0830
79.8810
158.7850
Other Income Expense
1,214.3330
1,214.3330
432.3470
208.6590
--
Pretax Income
-1,641.8090
-1,641.8090
-7,749.8560
-3,953.1400
-2,283.9110
Net Income Common Stockholders
-1,641.8090
-1,641.8090
-7,749.8560
-3,953.1400
-2,283.9110
Basic EPS
-0.02
--
-0.10
-0.05
-0.03
Diluted EPS
-0.02
--
-0.10
-0.05
-0.03
Basic Average Shares
75,153.8480
--
75,153.8480
75,153.8480
75,153.8480
Diluted Average Shares
75,153.8480
--
75,153.8480
75,153.8480
75,153.8480
Net Income from Continuing & Discontinued Operation
-1,641.8090
-1,641.8090
-7,749.8560
-3,953.1400
-2,283.9110
Normalized Income
-1,641.8090
-1,641.8090
-7,749.8560
-3,953.1400
-2,283.9110
Interest Income
491.8180
491.8180
797.0830
79.8810
158.7850
Net Interest Income
491.8180
491.8180
797.0830
79.8810
158.7850
EBIT
-3,347.9600
-3,347.9600
-8,979.2860
-4,241.6800
-2,442.6960
EBITDA
-3,347.9600
-3,347.9600
-8,979.2860
-4,241.6800
-2,442.6960
Net Income from Continuing Operation Net Minority Interest
-1,641.8090
-1,641.8090
-7,749.8560
-3,953.1400
-2,283.9110
Total Unusual Items Excluding Goodwill
-117.9460
--
--
--
--
Total Unusual Items
-117.9460
--
--
--
--
Normalized EBITDA
-3,347.9600
-3,347.9600
-8,979.2860
-4,241.6800
-2,442.6960
6/30/2021 - 7/5/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers